China to pass new foreign investment law in the wake of a trade war
By Akshay Kedari  Date: 2019-03-04

China to pass new foreign investment law in the wake of a trade war

China is said to maintain a highly clear policy with respect to its relationship with the United States.

China is reportedly on the verge of passing a novel foreign investment law in a bid to level the playing field for investors worldwide equipped with legal safeguards on technology transfer and IPR. Sources familiar with the knowledge of the matter claim that these were a part of some of the demands of President Donald Trump drawn up to end the trade war between both the countries.

Reportedly, China and the United States have been embroiled in an ugly trade war ever since the imposition of heavy tariffs on aluminum and steel items imported from China, by President Trump, since March last year. In consequence, China went on to impose heavy tariffs on American imports worth billions of dollars, the result of which sparked fears worldwide regarding a trade war.

In a bid to reach the end of the tunnel, China has scrambled up to hurriedly pass the new foreign investment law, that will apparently be submitted to the National People's Congress (NPC) – the top legislature, for a review. Speaking on the urgency of delivering the same, Zhang Yesui, spokesperson, NPC, was quoted stating that the interests of both the nations are severely interwoven and a U.S.-China relationship on the brink of conflict is not in anyone’s interest.

Elaborating further, Zhang asserts that China maintains a highly clear policy with respect to its relationship with the United States, that seemingly is not encompassed with conflicts, but is based on a no-confrontation, win-win, mutual respect cooperation.

Reliable reports affirm that major details of the deal are still largely unsettled, given that pivotal discussions are still on the go. However, according to The New York Times, both the nations seem to have agreed on a certain pact that may entail Beijing to make mammoth purchases of American energy and agricultural goods and also reduce specific barriers that have been restraining American firms from operating in China.

Also, it is being speculated that the U.S. may,  in turn, drop its tariffs on perhaps a minimum of USD 200 billion of the USD 250 billion worth of Chinese imports that are presently subject to American levies.

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

BMW drivers can now unlock and start cars without using their iPhone
BMW drivers can now unlock and start cars without using their iPhone
By Akshay Kedari

German multinational automobile manufacturer, Bayerische Motoren Werke AG, commonly known as BMW, has reportedly unveiled an upgraded version of its mobile car key technology, called the Digital Key Plus. This product enables iPhone users to unlock t...

FMCG firms resort to marginal hike to cope with raw material inflation
FMCG firms resort to marginal hike to cope with raw material inflation
By Akshay Kedari

The recent inflation in raw materials has reportedly prompted players in the FMCG sector to take price hike measures for their products, in a bid to maintain the revenues. According to reliable sources, some FMCG companies, including Marico, have al...

boAt raises USD 100 million in funding from Warburg Pincus
boAt raises USD 100 million in funding from Warburg Pincus
By Akshay Kedari

Indian consumer electronics brand, boAt, has reportedly secured funding of USD 100 million from Warburg Pincus, a New-York-based private equity firm, at a USD 300 million valuation. The company will utilize these funds to expand its product portfoli...

Elevar Therapeutics and Inceptua partner to commercialize Apealea®
Elevar Therapeutics and Inceptua partner to commercialize Apealea®
By Akshay Kedari

According to reliable sources, U.S.-based fully integrated biopharmaceutical company, Elevar Therapeutics Inc., has signed an exclusive agreement with Inceptua Group for the commercialization and distribution of its non-cremophor based paclitaxel tre...

NASA completes construction of ‘LC-48’ at Kennedy Space Center
NASA completes construction of ‘LC-48’ at Kennedy Space Center
By Akshay Kedari

The National Aeronautics and Space Administration (NASA) has reportedly announced the completion of the construction of its new launchpad at the Kennedy Space Center based in Florida. Notably, the new Launch Complex 48 or LC-48 is a pad that will be ...